首页 > 最新文献

Cardiac Cath Lab Director最新文献

英文 中文
Do Evidence-Based Clinical Guidelines Do More Harm Than Good? 循证临床指南弊大于利吗?
Pub Date : 2011-02-01 DOI: 10.1177/2150133510388639
K. Musunuru
{"title":"Do Evidence-Based Clinical Guidelines Do More Harm Than Good?","authors":"K. Musunuru","doi":"10.1177/2150133510388639","DOIUrl":"https://doi.org/10.1177/2150133510388639","url":null,"abstract":"","PeriodicalId":320506,"journal":{"name":"Cardiac Cath Lab Director","volume":"92 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123124093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary Stent Fracture 冠状动脉支架骨折
Pub Date : 2011-02-01 DOI: 10.1177/2150133510395496
R. Nair, K. Quadros
Coronary stent fracture is a relatively uncommon and rare complication of stent implantation. The reported incidence of stent fracture among drug-eluting stents ranges from 1% to 8%. Since 2003, when the use of drug-eluding stents was approved by the FDA for the treatment of coronary atherosclerosis, a number of retrospective and prospective studies and case reports have been published. We reviewed these publications to determine the incidence, predictors, clinical implications, and different management strategies for drug-eluding stent fracture in the coronary arteries. A review of the literature showed that the risk for stent fracture was higher with right coronary artery location, increased vessel tortuosity and angulation prior to stenting, use of overlapping stents, and use of longer stents. A higher risk of bare metal stent fracture was reported in saphenous vein bypass grafts. The authors also report in this issue in the Department “Case Study” a symptomatic fracture of a sirolimus-eluding Cypher® stent in the mid-left anterior descending artery.
冠状动脉支架骨折是一种相对少见的支架植入并发症。据报道,药物洗脱支架中支架断裂的发生率在1%到8%之间。自2003年FDA批准使用药物规避支架治疗冠状动脉粥样硬化以来,已经发表了许多回顾性和前瞻性研究以及病例报告。我们回顾了这些出版物,以确定冠状动脉药物逃避支架骨折的发生率、预测因素、临床意义和不同的处理策略。文献回顾显示,支架骨折的风险较高的是右冠状动脉位置,支架植入前血管扭曲和成角增加,使用重叠支架和使用较长的支架。据报道,隐静脉旁路移植术中裸金属支架骨折的风险较高。作者还在本刊的“病例研究”中报道了一例在左前降支中植入西罗莫司的Cypher®支架的症状性骨折。
{"title":"Coronary Stent Fracture","authors":"R. Nair, K. Quadros","doi":"10.1177/2150133510395496","DOIUrl":"https://doi.org/10.1177/2150133510395496","url":null,"abstract":"Coronary stent fracture is a relatively uncommon and rare complication of stent implantation. The reported incidence of stent fracture among drug-eluting stents ranges from 1% to 8%. Since 2003, when the use of drug-eluding stents was approved by the FDA for the treatment of coronary atherosclerosis, a number of retrospective and prospective studies and case reports have been published. We reviewed these publications to determine the incidence, predictors, clinical implications, and different management strategies for drug-eluding stent fracture in the coronary arteries. A review of the literature showed that the risk for stent fracture was higher with right coronary artery location, increased vessel tortuosity and angulation prior to stenting, use of overlapping stents, and use of longer stents. A higher risk of bare metal stent fracture was reported in saphenous vein bypass grafts. The authors also report in this issue in the Department “Case Study” a symptomatic fracture of a sirolimus-eluding Cypher® stent in the mid-left anterior descending artery.","PeriodicalId":320506,"journal":{"name":"Cardiac Cath Lab Director","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123511044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Evaluation of Nephropathy in Coronary Catheterization 冠状动脉置管术中肾病的评价
Pub Date : 2011-02-01 DOI: 10.1177/2150133510395574
B. J. Berger
Cath lab managers are involved in quality assurance and outcomes evaluation. One area of focus is contrast-induced nephropathy (CIN). CIN is important because it is the third leading cause of hospital-associated renal insufficiency, and even when it is clinically reversible it is associated with increased hospitalization, cost, and mortality. Assessment of nonmodifiable risk factors, treatment of modifiable risk factors, and evaluation of laboratory biomarkers is essential as predictors of CIN and to long-term survival.
导管实验室管理人员参与质量保证和结果评估。一个重点领域是造影剂肾病(CIN)。CIN很重要,因为它是医院相关性肾功能不全的第三大原因,即使在临床上是可逆的,它也与住院率、费用和死亡率的增加有关。不可改变的危险因素的评估,可改变的危险因素的治疗和实验室生物标志物的评估是至关重要的预测CIN和长期生存。
{"title":"Evaluation of Nephropathy in Coronary Catheterization","authors":"B. J. Berger","doi":"10.1177/2150133510395574","DOIUrl":"https://doi.org/10.1177/2150133510395574","url":null,"abstract":"Cath lab managers are involved in quality assurance and outcomes evaluation. One area of focus is contrast-induced nephropathy (CIN). CIN is important because it is the third leading cause of hospital-associated renal insufficiency, and even when it is clinically reversible it is associated with increased hospitalization, cost, and mortality. Assessment of nonmodifiable risk factors, treatment of modifiable risk factors, and evaluation of laboratory biomarkers is essential as predictors of CIN and to long-term survival.","PeriodicalId":320506,"journal":{"name":"Cardiac Cath Lab Director","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127011939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anomalous Left Main Coronary Artery From Right Coronary Cusp 左主冠状动脉与右冠状动脉尖异常
Pub Date : 2011-02-01 DOI: 10.1177/2150133510395102
Molly Szerlip, P. Suryanarayana, U. Luft
Anomalous origin of the left main coronary artery is a rare clinical entity that can present with symptoms across the clinical gamut, from asymptomatic to chest pain and possibly even sudden death. The clinical syndrome varies depending on the course of the aberrant left main. The anterior course where the artery runs between the aorta and the pulmonary artery can lead to compression of the left main, resulting in ischemia and possibly sudden death. In this article, the authors describe a case of a left main arising from the right coronary cusp that took a posterior course. There was a high-grade, proximal left anterior descending artery lesion that was treated with percutaneous intervention after defining the course of the aberrant left main.
冠状动脉左主干起源地异常是一种罕见的临床表现,其临床症状从无症状到胸痛,甚至可能猝死。临床表现随左主干异常病程的不同而不同。动脉在主动脉和肺动脉之间的前段可导致左主干受压,导致缺血,并可能导致猝死。在这篇文章中,作者描述了一个左主干产生于右冠状动脉尖,并采取后程的情况。有一个高度,近端左前降支病变,在确定了异常左主干的病程后,经皮介入治疗。
{"title":"Anomalous Left Main Coronary Artery From Right Coronary Cusp","authors":"Molly Szerlip, P. Suryanarayana, U. Luft","doi":"10.1177/2150133510395102","DOIUrl":"https://doi.org/10.1177/2150133510395102","url":null,"abstract":"Anomalous origin of the left main coronary artery is a rare clinical entity that can present with symptoms across the clinical gamut, from asymptomatic to chest pain and possibly even sudden death. The clinical syndrome varies depending on the course of the aberrant left main. The anterior course where the artery runs between the aorta and the pulmonary artery can lead to compression of the left main, resulting in ischemia and possibly sudden death. In this article, the authors describe a case of a left main arising from the right coronary cusp that took a posterior course. There was a high-grade, proximal left anterior descending artery lesion that was treated with percutaneous intervention after defining the course of the aberrant left main.","PeriodicalId":320506,"journal":{"name":"Cardiac Cath Lab Director","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129846860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
IV Catheter Care and Maintenance Minimizes Catheter-Related Blood Stream Infection 静脉导管护理和维护可最大限度地减少导管相关血流感染
Pub Date : 2011-02-01 DOI: 10.1177/2150133510395572
D. Macklin
The elimination of catheter-related bloodstream infections (CR-BSI) requires meticulous intravenous (IV) catheter care. There are three different types of needlefree connectors and one intraluminal protection device that require different care regimens, including the correct usage of disinfectants, flushing techniques, and clamping sequences. The nurse must be able to identify which connector is in use and select the appropriate care. This care must be followed not only in the inpatient unit by the bedside nurse but also in areas that are providing diagnostic procedures such as the cardiac cath lab. Since bacterial adhesion to the intraluminal catheter wall is the primary building block of a CR-BSI, which may not present until days after initial inoculation, preventing intraluminal fluid pathway contamination is paramount with every access. In addition, many institutions have more than one type of connector available. This complicates the provision of consistent safe care. Split septum, negative mechanical valves, positive pressure mechanical valves, and intraluminal protection devices have specific care and maintenance requirements. This article discusses the different connector types, why each requires special care, how intraluminal fluid pathway contamination can lead to CR-BSI, and how simple nursing care and maintenance practices of connector septum swabbing and catheter flushing by the cardiac cath nurse can help prevent this serious complication.
消除导管相关血流感染(CR-BSI)需要细致的静脉(IV)导管护理。有三种不同类型的无针连接器和一种腔内保护装置,需要不同的护理方案,包括正确使用消毒剂、冲洗技术和夹紧顺序。护士必须能够识别正在使用的连接器并选择适当的护理。这种护理不仅必须在住院病房由床边护士遵循,而且在提供诊断程序的领域,如心导管实验室也必须遵循。由于细菌粘附在腔内导管壁上是CR-BSI的主要组成部分,可能在初次接种后几天才出现,因此防止腔内液体通路污染对每次访问都至关重要。此外,许多机构有多种类型的连接器可用。这使得提供一致的安全护理变得复杂。隔膜分裂、负机械阀、正压机械阀和腔内保护装置都有特定的保养和维护要求。本文讨论了不同类型的连接器,为什么每种连接器都需要特殊护理,腔内液体通道污染如何导致CR-BSI,以及导管护士如何通过简单的护理和维护连接器隔膜擦拭和导管冲洗来帮助预防这种严重并发症。
{"title":"IV Catheter Care and Maintenance Minimizes Catheter-Related Blood Stream Infection","authors":"D. Macklin","doi":"10.1177/2150133510395572","DOIUrl":"https://doi.org/10.1177/2150133510395572","url":null,"abstract":"The elimination of catheter-related bloodstream infections (CR-BSI) requires meticulous intravenous (IV) catheter care. There are three different types of needlefree connectors and one intraluminal protection device that require different care regimens, including the correct usage of disinfectants, flushing techniques, and clamping sequences. The nurse must be able to identify which connector is in use and select the appropriate care. This care must be followed not only in the inpatient unit by the bedside nurse but also in areas that are providing diagnostic procedures such as the cardiac cath lab. Since bacterial adhesion to the intraluminal catheter wall is the primary building block of a CR-BSI, which may not present until days after initial inoculation, preventing intraluminal fluid pathway contamination is paramount with every access. In addition, many institutions have more than one type of connector available. This complicates the provision of consistent safe care. Split septum, negative mechanical valves, positive pressure mechanical valves, and intraluminal protection devices have specific care and maintenance requirements. This article discusses the different connector types, why each requires special care, how intraluminal fluid pathway contamination can lead to CR-BSI, and how simple nursing care and maintenance practices of connector septum swabbing and catheter flushing by the cardiac cath nurse can help prevent this serious complication.","PeriodicalId":320506,"journal":{"name":"Cardiac Cath Lab Director","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128728900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Transradial Versus Transfemoral Approach in Coronary Angiography and Intervention 经桡动脉与经股动脉入路在冠状动脉造影和介入中的应用
Pub Date : 2011-02-01 DOI: 10.1177/2150133510393496
S. Kanjanauthai, R. Napier, T. Raja, V. Arora
It is still debated whether a transradial approach or a transfemoral approach is better for coronary angiography or percutaneous coronary intervention. This article will provide a focused review on different aspects of the two approaches.
对于冠状动脉造影或经皮冠状动脉介入治疗,经桡动脉入路和经股动脉入路孰优孰优仍有争议。本文将重点回顾这两种方法的不同方面。
{"title":"Transradial Versus Transfemoral Approach in Coronary Angiography and Intervention","authors":"S. Kanjanauthai, R. Napier, T. Raja, V. Arora","doi":"10.1177/2150133510393496","DOIUrl":"https://doi.org/10.1177/2150133510393496","url":null,"abstract":"It is still debated whether a transradial approach or a transfemoral approach is better for coronary angiography or percutaneous coronary intervention. This article will provide a focused review on different aspects of the two approaches.","PeriodicalId":320506,"journal":{"name":"Cardiac Cath Lab Director","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132586820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Management 管理
Pub Date : 2011-02-01 DOI: 10.1177/2150133510395931
D. Scharbach
A series of articles regarding management techniques.
关于管理技术的一系列文章。
{"title":"Management","authors":"D. Scharbach","doi":"10.1177/2150133510395931","DOIUrl":"https://doi.org/10.1177/2150133510395931","url":null,"abstract":"A series of articles regarding management techniques.","PeriodicalId":320506,"journal":{"name":"Cardiac Cath Lab Director","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117348482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ACVP Update ACVP更新
Pub Date : 2011-02-01 DOI: 10.1177/2150133510395714
Peggy McElgunn
{"title":"ACVP Update","authors":"Peggy McElgunn","doi":"10.1177/2150133510395714","DOIUrl":"https://doi.org/10.1177/2150133510395714","url":null,"abstract":"","PeriodicalId":320506,"journal":{"name":"Cardiac Cath Lab Director","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129711478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Dose Benchmarking 患者剂量基准
Pub Date : 2011-02-01 DOI: 10.1177/2150133510391244
J. Robins
With the focus on radiation dose to patients becoming more prevalent in the past few months, steps need to be taken to ensure the safe use of fluoroscopy for patients coming to the cardiovascular lab for procedures that are becoming more and more complex. Technology exists within newer imaging systems that allows providers to establish benchmarks with respect to patient dose and therefore create protocols that will automatically trigger quality review of patients who receive a relatively high dose.
在过去的几个月里,随着对患者辐射剂量的关注变得越来越普遍,需要采取措施,确保到心血管实验室进行越来越复杂的检查的患者安全使用透视。较新的成像系统中存在的技术允许提供者建立有关患者剂量的基准,从而制定方案,自动触发对接受相对高剂量患者的质量审查。
{"title":"Patient Dose Benchmarking","authors":"J. Robins","doi":"10.1177/2150133510391244","DOIUrl":"https://doi.org/10.1177/2150133510391244","url":null,"abstract":"With the focus on radiation dose to patients becoming more prevalent in the past few months, steps need to be taken to ensure the safe use of fluoroscopy for patients coming to the cardiovascular lab for procedures that are becoming more and more complex. Technology exists within newer imaging systems that allows providers to establish benchmarks with respect to patient dose and therefore create protocols that will automatically trigger quality review of patients who receive a relatively high dose.","PeriodicalId":320506,"journal":{"name":"Cardiac Cath Lab Director","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125515881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiac Cath Lab Director
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1